Canaccord Boosts PT on Aegerion (AEGR) to $90 Following Juxtapid Surveys
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
JP Morgan More Bullish on Aegerion (AEGR) Following Doc Conversations
May 29, 2013 12:14 PM EDTAegerion Pharmaceuticals (NASDAQ: AEGR) is a bright spot in the market Wednesday as positive analyst commentary has pushed the stock up 11.6%.
In addition to some others on the sell side, J.P. Morgan's Cory Kasimov issued bullish commentary after discussions with doctors about the company's... More
